Rani Therapeutics Holdings, Inc.
RANI· Nasdaq
Released Mar 22, 2023, after the close
10-K filed Mar 22, 2023, 81 days after period end · 0000950170-23-009178
derived · Computed from the longer spans the company filed.
| Metric | Q4 2022dderived from reported figures | Q4 2021dderived from reported figures | Q4 2020dderived from reported figures |
|---|---|---|---|
| Revenue | — | $0.00 | — |
| Net Income | -$8.79M | $5.89M | -$5.76M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Rani Therapeutics Holdings, Inc. · CIK 1856725 · Engraved from SEC EDGAR